Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ovarian Cycle01:27

Ovarian Cycle

3.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.2K
Oogenesis02:07

Oogenesis

68.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.7K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

3.8K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.8K
Proliferative Phase01:20

Proliferative Phase

1.2K
The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
1.2K
Transcytosis of IgG01:15

Transcytosis of IgG

4.0K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.0K
Infertility in Females01:28

Infertility in Females

3.6K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Anti-Phosphatidylserine/Prothrombin Antibodies and the Lectin Complement Pathway in Anti-Phospholipid Antibody-Associated Preterm Delivery.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

The impact of gut microbiome on intrahepatic cholestasis of pregnancy-systematic literature review.

Frontiers in medicine·2026
Same author

Editorial: Community series in the immunological role of the maternal microbiome in pregnancy, Volume II.

Frontiers in immunology·2026
Same author

The Impact of Thyroid Autoimmunity, Glucose Metabolism, and Vitamin D Status in Women With Recurrent Pregnancy Loss: A Retrospective Study.

Endocrine, metabolic & immune disorders drug targets·2026
Same author

Role of Lifestyle and Nutrition in Menstrual Cycle Regularity: Associations with Body Composition and Dietary Habits.

Journal of clinical medicine·2026
Same author

T-shaped uterus metroplasty is associated with increased live birth rate in women with recurrent pregnancy loss: evidence form a matched case-control study.

Journal of minimally invasive gynecology·2026

Related Experiment Video

Updated: Jan 4, 2026

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
07:46

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Published on: October 13, 2023

1.7K

Endometrial Immune Dysfunction in Recurrent Pregnancy Loss.

Carlo Ticconi1, Adalgisa Pietropolli1, Nicoletta Di Simone2,3

  • 1Department of Surgical Sciences, Section of Gynecology and Obstetrics, University Tor Vergata, Via Montpellier, 1, 00133 Rome, Italy.

International Journal of Molecular Sciences
|November 14, 2019
PubMed
Summary

Recurrent pregnancy loss (RPL) affects 5% of couples and is often unexplained. This review explores how endometrial immune dysfunction may cause RPL, focusing on immune cells and molecular pathways.

Keywords:
deciduaendometriumimmunologic dysfunctionrecurrent pregnancy loss

More Related Videos

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
05:16

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

3.7K
Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy
08:29

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy

Published on: October 25, 2024

1.7K

Related Experiment Videos

Last Updated: Jan 4, 2026

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
07:46

Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells

Published on: October 13, 2023

1.7K
Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
05:16

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage

Published on: August 4, 2021

3.7K
Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy
08:29

Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy

Published on: October 25, 2024

1.7K

Area of Science:

  • Reproductive immunology
  • Gynecology and obstetrics

Background:

  • Recurrent pregnancy loss (RPL) affects approximately 5% of couples trying to conceive.
  • Nearly 50% of RPL cases remain unexplained, highlighting gaps in current understanding.
  • The endometrium plays a crucial role in maternal-fetal immune tolerance, essential for successful pregnancy.

Purpose of the Study:

  • To review the immunologic pathways, cells, and molecular factors involved in endometrial dysfunction.
  • To explore the potential role of endometrial immune dysregulation in unexplained RPL.
  • To provide insights into the complex maternal-fetal immune dialogue at the endometrial level.

Main Methods:

  • Literature review of experimental studies on endometrial immunology and RPL.
  • Analysis of immune cells and molecular determinants in the maternal-fetal interface.
  • Focus on immunologic pathways implicated in endometrial dysfunction.

Main Results:

  • Emerging evidence suggests endometrial immune dysregulation is a significant factor in RPL.
  • Complex immunologic events involving various immune cells and molecules occur at the maternal-fetal interface.
  • Specific pathways and molecular determinants are being identified as potential contributors to RPL.

Conclusions:

  • Endometrial immune dysregulation is a promising area for understanding unexplained RPL.
  • Further research into these immunologic factors could lead to new diagnostic and therapeutic strategies.
  • Understanding the endometrial immune dialogue is key to addressing RPL.